SFG
CLGN icon

Strive Financial Group’s CollPlant Biotechnologies CLGN Stock Holding History

Strive Financial Group’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59 Buy
+17
New +$65 ﹤0.01% 832

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Strive Financial Group's CLGN Position: Q2 2026 in Review

Strive Financial Group opened a new position in CollPlant Biotechnologies (CLGN) in Q2 2026: 17 shares worth $59. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings.

15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Strive Financial Group held 17 shares of CollPlant Biotechnologies worth $59 as of Q2 2026.
  • CollPlant Biotechnologies was a new Strive Financial Group position in Q2 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #832 holding.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.